Provided by Tiger Fintech (Singapore) Pte. Ltd.

Praxis Precision Medicines, Inc.

40.24
+2.185.73%
Post-market: 40.240.00000.00%19:57 EDT
Volume:512.73K
Turnover:20.43M
Market Cap:811.37M
PE:-3.94
High:40.84
Open:38.76
Low:38.21
Close:38.06
Loading ...

Praxis Precision Medicines Shares Promising EMBOLD Study Data

TIPRANKS
·
03 May

BRIEF-Praxis Precision Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
03 May

Press Release: Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Dow Jones
·
03 May

Praxis Precision Medicine Q1 EPS $(3.29) Misses $(3.17) Estimate

Benzinga
·
02 May

BRIEF-Praxis Precision Q1 EPS USD -3.29 Vs. IBES Estimate USD -3.2

Reuters
·
02 May

Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2025 Financial Results

THOMSON REUTERS
·
02 May

Praxis Precision Medicines Inc - Maintains Runway Into 2028

THOMSON REUTERS
·
02 May

Praxis Precision Q1 Net Income USD -69.296 Million VS. Ibes Estimate USD -64.3 Million

THOMSON REUTERS
·
02 May

Praxis Precision Q1 EPS USD -3.29 VS. Ibes Estimate USD -3.2

THOMSON REUTERS
·
02 May

Press Release: Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2025 Financial Results

Dow Jones
·
02 May

Praxis Precision Med Price Target Maintained With a $105.00/Share by HC Wainwright & Co.

Dow Jones
·
01 May

Praxis Precision Medicines to Hold Virtual Investor Event to Discuss Clinical Programs in Developmental and Epileptic Encephalopathies

GlobeNewswire
·
08 Apr

Praxis Precision Med Price Target Maintained With a $85.00/Share by Needham

Dow Jones
·
08 Apr

BRIEF-Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
04 Apr

Praxis Precision Medicines to Participate in Upcoming April Conferences

GlobeNewswire
·
04 Apr

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
04 Apr

Praxis Precision Medicines to Present on Late-Stage Programs across Epilepsy and Movement Disorders at the American Academy of Neurology 2025 Annual Meeting

GlobeNewswire
·
24 Mar

Stock Track | Praxis Precision Medicines Plummets 5.4% Following Disappointing Q4 Earnings and Financial Update

Stock Track
·
06 Mar

Praxis Precision Medicines Updates on Programs and Finances

TIPRANKS
·
06 Mar

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
05 Mar